QIAGEN N.V. Cost of Revenue
QIAGEN N.V. (QGEN) reported Cost of Revenue of $790.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-03-20
| Period end | Cost of Goods and Services Sold 12 month |
|---|---|
| 2025-12-31 | $790.50M 20-F · filed 2026-03-20 |
| 2024-12-31 | $1.01B 20-F · filed 2026-03-20 |
| 2023-12-31 | $731.62M 20-F · filed 2026-03-20 |
| 2022-12-31 | $756.96M 20-F · filed 2025-03-31 |
| 2021-12-31 | $800.84M 20-F · filed 2024-03-11 |
| 2020-12-31 | $637.63M 20-F · filed 2023-03-13 |
| 2019-12-31 | $521.16M 20-F · filed 2022-03-14 |
| 2018-12-31 | $500.89M 20-F · filed 2021-03-05 |
| 2017-12-31 | $494.98M 20-F · filed 2020-03-02 |
| 2016-12-31 | $493.34M 20-F · filed 2019-03-06 |